Search results :

Ustekinumab

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: L04AC05

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3
Nasopharyngitis Nasopharyngitis very common, 8% 8% x x x
Arthralgia Arthralgia common x x x
Musculoskeletal discomfort Arthralgia common x x x
Myalgia common, 1% 1% x x x
Back pain Back pain common, 1% 1% x x x
Diarrhoea Diarrhoea common, 2% 2% x x x
Dizziness Dizziness common, 1% 1% x x x
Asthenia Fatigue common, 3% 2% x x x
Fatigue Fatigue common, 3% 2% x x x
Headache Headache common, 5% 3% x x x
Nausea Nausea common x x x
Upper respiratory tract infection Upper respiratory tract infection common — 5% 5% x x x
Injection site pain Injection site pain common x x
Myalgia Myalgia common, 1% 1% x x x
Viral upper respiratory tract infection Viral upper respiratory tract infection common x
Injection site erythema Injection site erythema common, 1% 1% x x x
Tooth infection Tooth infection common x x x
Oropharyngeal pain Oropharyngeal pain common x
Pruritus Pruritus uncommon — 2% 1% x x x
Laryngeal pain Pharyngolaryngeal pain common, 1% 1% x x
Cellulitis Cellulitis uncommon, common x x x
Nasal congestion Nasal congestion uncommon, common x x
Depression Depression uncommon — 1% 1% x x x
Contusion Contusion uncommon x x
Dermatitis Rash postmarketing — common x x x
Rash Rash postmarketing — common x x x
VIIth nerve paralysis Facial paralysis uncommon x
Haemorrhage Haemorrhage uncommon x x x
Haemoglobin Haemorrhage uncommon x x x
Herpes zoster Herpes zoster uncommon x x x
Swelling Swelling uncommon x x x
Urticaria Urticaria postmarketing — common x x x
Injection site reaction Injection site reaction uncommon x x x
Pustular psoriasis Pustular psoriasis postmarketing, uncommon x x x
Induration Induration uncommon x x x
Anaphylactic shock Anaphylactic shock postmarketing, rare x x x
Angioedema Angioedema postmarketing, rare x x x
Hypersensitivity Hypersensitivity postmarketing — common x x x
Immune system disorder Immune system disorder postmarketing x x x
Erythrodermic psoriasis Erythrodermic psoriasis postmarketing x
Anxiety Anxiety x
Appendicitis Appendicitis x
Mental disorder Mental disorder x x
Breast cancer Breast cancer x
Neoplasm malignant Neoplasm malignant x x x
Skin cancer Skin cancer x x
Skin carcinoma x x x
Cholecystitis Cholecystitis x
Infection Infection x x x
Connective tissue disorder Connective tissue disorder x
Diverticulitis Diverticulitis x x x
Gastroenteritis Gastroenteritis x
Gastrointestinal disorder Gastrointestinal disorder x x
Haematoma Haematoma x
Mediastinal disorder Mediastinal disorder x x
Malignant melanoma Malignant melanoma x x x
Melanoma skin x x
Myocardial infarction Myocardial infarction x
Acute coronary syndrome Myocardial infarction x
Nervous system disorder Nervous system disorder x x
Osteomyelitis Osteomyelitis x
Pain Pain x
Pneumonia Pneumonia x x
Cerebrovascular accident Cerebrovascular accident x
Tuberculosis Tuberculosis x x
Urinary tract infection Urinary tract infection x
Viral infection Viral infection x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Sepsis Sepsis x
Infestation Infestation NOS x x
Posterior reversible encephalopathy syndrome Posterior reversible encephalopathy syndrome x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ustekinumab

Side effects:38
Source:FDA Structured Product Label

ustekinumab / ustekinumab

Side effects:50
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label